Michael D. Cameron

11.4k total citations · 2 hit papers
171 papers, 7.5k citations indexed

About

Michael D. Cameron is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Michael D. Cameron has authored 171 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Molecular Biology, 28 papers in Cellular and Molecular Neuroscience and 26 papers in Organic Chemistry. Recurrent topics in Michael D. Cameron's work include Receptor Mechanisms and Signaling (25 papers), Neuropeptides and Animal Physiology (17 papers) and Melanoma and MAPK Pathways (16 papers). Michael D. Cameron is often cited by papers focused on Receptor Mechanisms and Signaling (25 papers), Neuropeptides and Animal Physiology (17 papers) and Melanoma and MAPK Pathways (16 papers). Michael D. Cameron collaborates with scholars based in United States, Brazil and China. Michael D. Cameron's co-authors include Theodore M. Kamenecka, Steven D. Aust, Claudia Ruiz, Derek R. Duckett, Xiaohai Li, Thomas D. Bannister, Laura Bohn, Cullen L. Schmid, Youseung Shin and Yuanjun He and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael D. Cameron

167 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists

2012 649 citations Michael D. Cameron, Theodore M. Kamenecka et al. profile →
Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics

2017 372 citations Cullen L. Schmid, Nicole Kennedy et al. profile →

Peers

Countries citing papers authored by Michael D. Cameron

Since Specialization

Citations

This map shows the geographic impact of Michael D. Cameron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Cameron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Cameron more than expected).

Fields of papers citing papers by Michael D. Cameron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Cameron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Cameron. The network helps show where Michael D. Cameron may publish in the future.

Co-authorship network of co-authors of Michael D. Cameron

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Cameron. A scholar is included among the top collaborators of Michael D. Cameron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Cameron. Michael D. Cameron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Combining spironolactone to antiretroviral therapy accelerates HIV decay in humanized mice 2025 ·Emerging Microbes & Infections ·Lijun Ling, Luisa Mori, (unknown), Wenbo Yao, (unknown), Ana Rachel Léda, Rae Ann Spagnuolo, (unknown), Martina Kovářová, (unknown), Michael D. Cameron, Susana Valente, J. Víctor García	0
2	SR9883 is a novel small-molecule enhancer of α4β2* nicotinic acetylcholine receptor signaling that decreases intravenous nicotine self-administration in rats 2024 ·Frontiers in Molecular Neuroscience ·(unknown), George Voren, Christie D. Fowler, Qun Lu, Alexander Kuryatov, Michael D. Cameron, Inés Ibáñez-Tallon, Jon Lindstrom, Theodore M. Kamenecka, Paul J. Kenny	2
3	Guardians at the Gate: Optimization of Small Molecule Entry Inhibitors of Ebola and Marburg Viruses 2024 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Arsen Gaisin, Mario Moisés Álvarez, Terry W. Moore, Fan Bu, Fang Li, Michael D. Cameron, Manu Anantpadma, Robert A. Davey, Norton P. Peet, Lijun Rong, Irina N. Gaisina	0
4	REM-422, a Small Molecule MYB mRNA Degrader, Demonstrates Anti-Leukemic Activity As Monotherapy and in Combination with Standards of Care in Preclinical Models of AML 2024 ·Blood ·(unknown), Michael Thomas, (unknown), (unknown), Alexander E. Ivliev, Adam Štefek, Michael D. Cameron, Sudeep Prajapati, Michael Seiler, Dominic J. Reynolds, Silvia Buonamici, Charles Kung	1
5	Basolateral amygdala corticotropin releasing factor receptor 2 interacts with nonmuscle myosin II to destabilize memory in males 2023 ·Neurobiology of Learning and Memory ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Li Lin, Susan Khan, Michael D. Cameron, Gavin Rumbaugh, Courtney A. Miller	3
6	HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents 2023 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Marina Candido Primi, (unknown), Claudia Ruiz, Thales Kronenberger, Stefan Laufer, Márcia Inês Goettert, Antti Poso, (unknown), (unknown), (unknown), Neuza Mariko Aymoto Hassimotto, Michael D. Cameron, Thomas D. Bannister, Letícia V. Costa‐Lotufo, João Agostinho Machado‐Neto, Maurício T. Tavares, Roberto Parise‐Filho	4
7	Dual Inhibitors of Main Protease (M^Pro) and Cathepsin L as Potent Antivirals against SARS-CoV2 2022 ·Journal of the American Chemical Society ·Santanu Mondal, Yongzhi Chen, G.J. Lockbaum, (unknown), (unknown), Archie C. Reyes, (unknown), (unknown), Nadia Sultana, Michael D. Cameron, Scott A. Shaffer, Celia A. Schiffer, Katherine A. Fitzgerald, Paul R. Thompson	31
8	Development of a putative Zn2+-chelating but highly selective MMP-13 inhibitor 2022 ·Bioorganic & Medicinal Chemistry Letters ·Rita Fuerst, (unknown), Anna M. Knapinska, Michael D. Cameron, Claudia Ruiz, Amber L. Delmas, Mark S. Sundrud, Gregg Fields, William Roush	8
9	Discovery of Selective Inhibitors for In Vitro and In Vivo Interrogation of Skeletal Myosin II 2021 ·ACS Chemical Biology ·László Radnai, M. D. Surman, (unknown), Erica J. Young, (unknown), Li Lin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), James R. Sellers, Michael D. Cameron, Gavin Rumbaugh, Patrick R. Griffin, Theodore M. Kamenecka, Courtney A. Miller	4
10	Structure–Activity Relationship and Biological Investigation of SR18292 (16), a Suppressor of Glucagon-Induced Glucose Production 2021 ·Journal of Medicinal Chemistry ·Hua Lin, Kfir Sharabi, Lin Li, Claudia Ruiz, Di Zhu, Michael D. Cameron, Scott J. Novick, Patrick R. Griffin, Pere Puigserver, Theodore M. Kamenecka	4
11	Oregano Oil and Its Principal Component, Carvacrol, Inhibit HIV-1 Fusion into Target Cells 2020 ·Journal of Virology ·Sonia Mediouni, Joseph Jablonski, (unknown), (unknown), Cari F. Kessing, Audrey S. Richard, Avik Biswas, (unknown), Viviane M. Andrade, Yasmine Even, Mario Stevenson, (unknown), Hyeryun Choe, Michael D. Cameron, Thomas D. Bannister, Susana T. Valente	45
12	Comparison of morphine, oxycodone and the biased MOR agonist SR-17018 for tolerance and efficacy in mouse models of pain 2020 ·Neuropharmacology ·(unknown), Travis W. Grim, Cullen L. Schmid, (unknown), Nicole Kennedy, Michael D. Cameron, Thomas D. Bannister, Laura Bohn	20
13	Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor 2019 ·Cancer Discovery ·Ciric To, Jaebong Jang, Ting Chen, Eunyoung Park, Mierzhati Mushajiang, Dries J.H. De Clercq, Man Xu, Stephen Wang, Michael D. Cameron, David E. Heppner, Bo Hee Shin, Thomas W. Gero, Annan Yang, Suzanne E. Dahlberg, Kwok‐Kin Wong, Michael J. Eck, Nathanael S. Gray, Pasi A. Jänne	250
14	Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model 2019 ·Proceedings of the National Academy of Sciences ·Alicia J. Angelbello, Suzanne G. Rzuczek, Kendra McKee, Jonathan L. Chen, Hailey Olafson, Michael D. Cameron, Walter N. Moss, Eric T. Wang, Matthew D. Disney	91
15	Fentanyl-related designer drugs W-18 and W-15 lack appreciable opioid activity in vitro and in vivo 2017 ·JCI Insight ·Xi‐Ping Huang, Tao Che, Thomas J. Mangano, Valerie Le Rouzic, Ying‐Xian Pan, Michael D. Cameron, Michael H. Baumann, Gavril W. Pasternak, Bryan L. Roth	17
16	Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria 2016 ·Science Signaling ·Tarsis F. Brust, Jenny Morgenweck, Susy A. Kim, Jamie H. Rose, Jason L. Locke, Cullen L. Schmid, Lei Zhou, Edward L. Stahl, Michael D. Cameron, Sarah M. Scarry, Jeffrey Aubé, Sara R. Jones, Thomas J. Martin, Laura Bohn	177
17	Amygdala-Dependent Fear Is Regulated by Oprl1 in Mice and Humans with PTSD 2013 ·Science Translational Medicine ·Raül Andero, Shaun P. Brothers, Tanja Jovanović, Yen T. Chen, (unknown), Michael D. Cameron, Thomas D. Bannister, Lynn M. Almli, Jennifer S. Stevens, Bekh Bradley, Elisabeth B. Binder, Claes Wahlestedt, Kerry J. Ressler	118
18	Synthesis of conolidine, a potent non-opioid analgesic for tonic and persistent pain 2011 ·Nature Chemistry ·Michael A. Tarselli, Kirsten M. Raehal, (unknown), John M. Streicher, Chad E. Groer, Michael D. Cameron, Laura Bohn, Glenn C. Micalizio	52
19	Insular hypocretin transmission regulates nicotine reward 2008 ·Proceedings of the National Academy of Sciences ·Jonathan A. Hollander, Qun Lu, Michael D. Cameron, Theodore M. Kamenecka, Paul J. Kenny	224
20	The diagnosis and differential diagnosis of granulocytic sarcoma 2008 ·Xiaoli, Feng, Jianming, Ying Ying, Michael D. Cameron, Yin Yin, Ling, ‡ Li, (unknown), Shi Shi, (unknown), Zhang, (unknown), Sun	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact